Manuel Häckl, MD

Rare Disease / Clinical Research

Basilea Pharmaceutica International Ltd, Allschwil

PI on 5 trials

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Invasive candidiasis
Combined hepatocellular carcinoma and cholangiocarcinoma
Crouzon syndrome
Adenocarcinoma of the oesophagus and oesophagogastric junction
Genetic bone tumor
Craniosynostosis
Jackson-Weiss syndrome
Congenital deformities of limbs
Congenital limb malformation
Genetic urogenital tumor
Dysostosis
Pfeiffer syndrome
Genetic congenital limb malformation
Genetic urogenital tract malformation
Apert syndrome
Carcinoma of liver and intrahepatic biliary tract
Urogenital tract malformation
Syndactyly type 2

Clinical trials (5)

NCT05421858
NCT03230318
NCT04045613
NCT04604132
NCT04087876

Verify independently

ClinicalTrials.gov PI search for Manuel Häckl, MD

Other specialists for Invasive candidiasis

Peers ranked by clinical-trial PI role, publications, and verification quality.

Robert Krause, MD
Medical University of Graz
Laura Cox, PhD
Mundipharma Research Limited
Shan-Chwen Chang, MD
National Taiwan University Hospital
Hana Slepčanová, Mgr.
University Hospital Ostrava
MJP van Wanrooy, PharmD
University Medical Center Groningen
Luigi Picaro
Gilead Sciences
Taylor Sandison, MD MPH
Cidara Therapeutics
WA
Jean-Francois TIMSIT, Professor
Assistance Publique - Hôpitaux de Paris

See all specialists for Invasive candidiasis →

← Back to specialists directory